Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Colorectal Neoplasms

  Free Subscription


Articles published in Ann Oncol

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    September 2021
  1. RAO S, Guren MG, Khan K, Brown G, et al
    Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up().
    Ann Oncol. 2021;32:1087-1100.
    PubMed    


    August 2021
  2. BROUWER NPM, Nagtegaal ID
    Tumor deposits improve staging in colon cancer: what are the next steps?
    Ann Oncol. 2021 Aug 17. pii: S0923-7534(21)03981.
    PubMed    


  3. YOSHINO T, Argiles G, Oki E, Martinelli E, et al
    Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis treatment and follow-up of patients with localised colon cancer.
    Ann Oncol. 2021 Aug 16. pii: S0923-7534(21)03982.
    PubMed     Abstract available


  4. KANAI M, Kawaguchi T, Kotaka M, Manaka D, et al
    Large-Scale Prospective Genome-Wide Association Study of Oxaliplatin in Stage II/III Colon Cancer and Neuropathy.
    Ann Oncol. 2021 Aug 12. pii: S0923-7534(21)03974.
    PubMed     Abstract available


    July 2021
  5. COHEN R, Shi Q, Meyers J, Jin Z, et al
    Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance).
    Ann Oncol. 2021 Jul 19. pii: S0923-7534(21)02187.
    PubMed     Abstract available


    June 2021
  6. TARPGAARD LS, Andersen PV, Ogaard N, Demuth C, et al
    Complete pathological and serological response to immunotherapy in a patient with MMR-deficient early rectal cancer.
    Ann Oncol. 2021;32:805-806.
    PubMed    


    April 2021
  7. GROTHEY A, Fakih M, Tabernero J
    Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines.
    Ann Oncol. 2021 Apr 6. pii: S0923-7534(21)01112.
    PubMed     Abstract available


    March 2021
  8. YUE Y, Hur J, Cao Y, Tabung FK, et al
    Prospective Evaluation of Dietary and Lifestyle Pattern Indices with Risk of Colorectal Cancer in a Cohort of Younger Women.
    Ann Oncol. 2021 Mar 31. pii: S0923-7534(21)01097.
    PubMed     Abstract available


  9. CARMONA-BAYONAS A, Jimenez-Fonseca P, Valenti V, Salazar R, et al
    Bayesian interpretation of the ESMO guideline for localized colorectal cancer: a better IDEA.
    Ann Oncol. 2021 Mar 16. pii: S0923-7534(21)00878.
    PubMed    


    November 2020
  10. GLYNNE-JONES R, Meadows HM, Lopes A, Muirhead R, et al
    Reply to the letter to the editor: DPD testing in radical chemoradiation for anal squamous cell carcinoma? by R. Muirhead, H. Jones, D. Gilbert, A. Gilbert & C. Jacobs.
    Ann Oncol. 2020;31:1587-1588.
    PubMed    


  11. JONES H, Gilbert D, Gilbert A, Jacobs C, et al
    DPD testing in radical chemoradiation for anal squamous cell carcinoma.
    Ann Oncol. 2020;31:1580.
    PubMed    


    October 2020
  12. YAMAZAKI K, Yamanaka T, Shiozawa M, Manaka D, et al
    Oxaliplatin-Based Adjuvant Chemotherapy Duration (3 vs. 6 Months) for High-Risk Stage II Colon Cancer: The Randomized Phase 3 ACHIEVE-2 Trial.
    Ann Oncol. 2020 Oct 26. pii: S0923-7534(20)42983.
    PubMed     Abstract available


  13. PRETTA A, Trevisi E, Bregni G, Deleporte A, et al
    Treatment compliance in early-stage anal cancer.
    Ann Oncol. 2020;31:1282-1284.
    PubMed    


  14. MANN EH, Maughan TS
    Fusobacterium nucleatum, rectal cancer and radiotherapy.
    Ann Oncol. 2020;31:1277-1278.
    PubMed    


  15. SERNA G, Ruiz-Pace F, Hernando J, Alonso L, et al
    Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer.
    Ann Oncol. 2020;31:1366-1375.
    PubMed     Abstract available


    September 2020
  16. JAIN A, Sjoquist K, Yip D
    ESMO Localized colon cancer guidelines: "Can we improve on our surveillance protocols?"
    Ann Oncol. 2020 Sep 22. pii: S0923-7534(20)42463.
    PubMed    


  17. BOSETTI C, Santucci C, Gallus S, La Vecchia C, et al
    Reply to the Letter to the Editor 'Aspirin to prevent gastrointestinal cancer - but recent trial data don't fit' by Jacobsen and colleagues.
    Ann Oncol. 2020;31:1263.
    PubMed    


  18. HOLCH JW, Heinemann V
    Reply to 'Cetuximab-related skin toxicity and efficacy: do we understand the mechanisms?' by Evesque et al.
    Ann Oncol. 2020;31:1261-1262.
    PubMed    


  19. JACOBSEN AP, Khiew YC, Blumenthal RS, Martin SS, et al
    Aspirin to prevent gastrointestinal cancer - but recent trial data do not fit.
    Ann Oncol. 2020;31:1262-1263.
    PubMed    


    August 2020
  20. SELIGMANN JF, Elliott F, Richman S, Hemmings G, et al
    Clinical and molecular characteristics and treatment outcomes of advanced right-colon, left-colon and rectal cancers: data from 1180 patients in a phase III trial of panitumumab with an extended biomarker panel.
    Ann Oncol. 2020;31:1021-1029.
    PubMed     Abstract available


    July 2020
  21. EVESQUE L, Francois E, Milano G
    Cetuximab-related skin toxicity and efficacy: do we understand the mechanisms?
    Ann Oncol. 2020;31:964-965.
    PubMed    


    May 2020
  22. BOSETTI C, Santucci C, Gallus S, Martinetti M, et al
    Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019.
    Ann Oncol. 2020;31:558-568.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: